Workout
Healthy Eating
Meditation
Podcast
Authenticity
Social Service
About Us
Review Board
Editorial Process
Contact Us
Health Tracker
AI Tools
✔Fact Checked

Barcelona prepare for unexpected transfer as RB Leipzig register interest in 25-year-old defender

One player who could be on the move in 2025 is Oscar Mingueza. The 25-year-old defender had a remarkable start to the season: two goals and three assists in the opening rounds, and although his scoring output has dried up since then, his impressive performances for Celta Vigo have continued.

One way or another, Mingueza’s situation will likely be resolved next summer. Celta wants to acquire the remaining 50% of his rights from Barcelona, ​​while offering him a contract beyond the expiration of his current contract, which ends in 2026.

However, he could end up being sold before this happens if a club pays the €20 million release clause in his contract. Relevo say that RB Leipzig have joined the race to sign Mingueza, whose sale would bring the much-needed sum of €10 million to Barcelona.

It remains to be seen where Mingueza ends up playing his football in the 2025-26 season. Celta are desperate to retain his services and although he is unlikely to return to Barcelona, ​​the Catalans could have a lot to say in the transfer process.

Last reviewed on

Expert Q&A

Ask a Question
Share Now:

Was this article helpful?

🤓

😕

dotdash removebg preview

FitToFar is part of the Dotdash Meredith publishing family.

Please review our updated Terms of Service.

BE THE FIRST TO KNOW

SUBSCRIBE TO GET LATEST FITNESS AND NUTRITION UPDATES!

We don’t spam! Read our privacy policy for more info.

The FitToFar News team takes pride in providing readers with accurate, properly sourced, and objectively analyzed content. Each news piece is stringently fact-checked by our Integrity Network, and any form of plagiarism or malicious behavior from our authors and contributors is strictly forbidden.

Our articles follow a number of key standards:

  • Each cited research and studies should come from renowned peer-reviewed journals or educational bodies. Additionally, any quoted data and figures must be traceable to its origin, while also detailing their significance.

  • Content related to treatment, medicine, and procedure must plainly specify availability, cost, possible side effects, targets, possible interactions, and unapproved usage (if relevant).

  • Every news article should have inputs from at least two authorized professionals, with corresponding qualifications and ties to appropriate associations or works.

  • The reader must be made aware of any potential conflict of interest relating to the source or study.

  • Finally, all news pieces should be supplied with enough background and context regarding the relevant topic or condition.